Administrative Burden of iPLEDGE Deters Isotretinoin Prescriptions: Results From a Survey of Dermatologists.
Sign Up to like & getrecommendations! Published in 2022 at "Cutis"
DOI: 10.12788/cutis.0558
Abstract: The requirements of the iPLEDGE program place burdens on both patients with severe recalcitrant nodular acne and prescribers of isotretinoin. We sought to investigate the changes in dermatologists' acne treatment patterns due to the administrative… read more here.
Keywords: burden ipledge; survey; ipledge; ipledge deters ... See more keywords
Differences in isotretinoin start, interruption, and early termination across race and sex in the iPLEDGE era
Sign Up to like & getrecommendations! Published in 2019 at "PLoS ONE"
DOI: 10.1371/journal.pone.0210445
Abstract: Background iPLEDGE is the mandatory regulatory program for isotretinoin in the United States, aimed to prevent isotretinoin-related teratogenicity. However, little is known about potential unintended impact of the program, including delay in isotretinoin initiation, course… read more here.
Keywords: differences isotretinoin; start interruption; isotretinoin start; ipledge ... See more keywords